|
|
|
|
pmid:28772237
|
|
|
|
|
pmid:28774557
|
|
|
|
|
pmid:28805201
|
|
|
|
|
pmid:28814613
|
Choi EM et al. |
Actein alleviates 2,3,7,8-tetrachlorodibenzo-p-dioxin-mediated cellular dysfunction in osteoblastic MC3T3-E1 cells. |
2017 |
Environ. Toxicol. |
pmid:28836330
|
Tschiderer L et al. |
Osteoprotegerin concentration and risk of cardiovascular outcomes in nine general population studies: Literature-based meta-analysis involving 26,442 participants. |
2017 |
PLoS ONE |
pmid:28837646
|
Ozaki Y et al. |
Treatment of OPG-deficient mice with WP9QY, a RANKL-binding peptide, recovers alveolar bone loss by suppressing osteoclastogenesis and enhancing osteoblastogenesis. |
2017 |
PLoS ONE |
pmid:28937990
|
|
|
|
|
pmid:28957555
|
|
|
|
|
pmid:29025654
|
|
|
|
|
pmid:29050490
|
|
|
|
|
pmid:29121799
|
|
|
|
|
pmid:29253005
|
|
|
|
|
pmid:29262817
|
|
|
|
|
pmid:29313442
|
|
|
|
|
pmid:29348072
|
|
|
|
|
pmid:29402836
|
Li N et al. |
Calycosin attenuates osteoporosis and regulates the expression of OPG/RANKL in ovariectomized rats MAPK signaling. |
2016 |
Pharmazie |
pmid:29441931
|
|
|
|
|
pmid:29502401
|
Simonet WS et al. |
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. |
1997 |
Cell |
pmid:9108485
|
Hofbauer LC and Heufelder AE |
Osteoprotegerin: a novel local player in bone metabolism. |
1997 |
Eur. J. Endocrinol. |
pmid:9368500
|